The impact of disruptions due to COVID-19 on HIV transmission and control among men who have sex with men in China

Booton RD, Fu G, MacGregor L, Li J, Ong JJ, Tucker JD, Turner KM, Tang W, Vickerman P, Mitchell KM.

COVID-19 & HIV/AIDS pandemics: Parallels & lessons

Dawa N, Narain JP.

COVID-19 in People Living with HIV: A Systematic Review and Meta-Analysis

Lee KW, Yap SF, Ngeow YF, Lye MS.

COVID-19 Vaccine Hesitancy among French People Living with HIV

Vallée A, Fourn E, Majerholc C, Touche P, Zucman D.

A SMART approach to treating tobacco use disorder in persons with HIV (SMARTTT): Rationale and design for a hybrid type 1 effectiveness-implementation study

Edelman EJ, Dziura J, Deng Y, Bold KW, Murphy SM, Porter E, Sigel KM, Yager JE, Ledgerwood DM, Bernstein SL.

'Test Now, Stop HIV': COVID-19 and the idealisation of quarantine as the 'end of HIV'

Ledin C, Weil B.

COVID/HIV Co-Infection: A Syndemic Perspective on What to Ask and How to Answer

Gesesew HA, Mwanri L, Stephens JH, Woldemichael K, Ward P.

Scaling Up Covid-19 Vaccination in Africa - Lessons from the HIV Pandemic

Nachega JB, Sam-Agudu NA, Mellors JW, Zumla A, Mofenson LM.

Turning threats into opportunities: how to implement and advance quality TB services for people with HIV during the COVID-19 pandemic and beyond

Roberts T, Sahu S, Malar J, Abdullaev T, Vandevelde W, Pillay YG, Fujiwara PI, Reid A, Hader S, Singh S, Kamarulzaman A, Ahmedov S.

Sulfoglycodendrimer Therapeutics for HIV-1 and SARS-CoV-2

Wells L, Vierra C, Hardman J, Han Y, Dimas D, Gwarada-Phillips LN, Blackeye R, Eggers DK, LaBranche CC, Král P, McReynolds KD.

The impact of the COVID-19 pandemic on STI/HIV testing among adolescents in a large pediatric primary care network

Bonett S, Petsis D, Dowshen N, Bauermeister J, Wood SM.

COVID-19 and Syndemic challenges in 'Battling the Big Three': HIV, TB and malaria

Velavan TP, Meyer CG, Esen M, Kremsner PG, Ntoumi F.

Persistent Immune activation in HIV-Infected Pregnant Women Initiating cART Post Conception

Lohman-Payne B, Koster J, Gabriel B, Chilengi R, Forman LS, Heeren T, Duffy CR, Herlihy J, Crimaldi S, Gill C, Chavuma R, Mwananyanda L, Thea DM.

Characterization of people living with HIV in a Montreal-based tertiary care center with COVID-19 during the first wave of the pandemic

Fehr D, Lebouché B, Ruppenthal L, Brownc M, Obasc N, Bourbonnière E, Girouard J, Massicotte A, Jenabian MA, Almomen AA, Frenette C, de Pokomandy A, Cox J, Giannakis A, Cheng M, Kronfli N, Tsoukas C, Zahedi N, Szabo J, Dehghani K, Brouillette MJ, Falutz J, Turner H, Hamel A, Duchesneau C, Lanthier-Brun J, Klein M, Routy JP, Costiniuk CT.

Effectively Confronting the COVID-19 Pandemic: Critical Lessons From HIV Prevention, Care, and Treatment and Innovative Strategies to Conduct Community-Based and Community-Engaged Research Safely

Rhodes SD, Sy FS.

Human rights and fair access to COVID-19 vaccines: the International AIDS Society-Lancet Commission on Health and Human Rights

Commissioners of and collaborators with the International AIDS Society–Lancet Commission on Health and Human Rights.

A collision of crises: Addressing an HIV outbreak among people who inject drugs in the midst of COVID-19

Taylor JL, Ruiz-Mercado G, Sperring H, Bazzi AR.

Increased HIV testing in people who use drugs hospitalized in the first wave of the COVID-19 pandemic

Zubiago J, Murphy M, Guardado R, Daudelin D, Patil D, Wurcel A.

The Impact of COVID-19 on Access to HIV Prevention Services Among Opioid-Dependent Individuals

Mistler CB, Curley CM, Rosen AO, El-Krab R, Wickersham JA, Copenhaver MM, Khati A, Shrestha R.

COVID-19: Prolonged viral shedding in an HIV patient with literature review of risk factors for prolonged viral shedding and its implications for isolation strategies

Yousaf M, Hameed M, Alsoub H, Khatib M, Jamal W, Ahmad M.

Let's apply the lessons from the AIDS crisis to the COVID-19 pandemic

Frierson R, Lippmann S.

Membraneless organelles restructured and built by pandemic viruses: HIV-1 and SARS-CoV-2

Scoca V, Di Nunzio F.

Sex Workers and Syndemics: A Population Vulnerable to HIV and COVID-19

Rogers BG, Paradis-Burnett A, Nagel K, Yolken A, Strong SH, Arnold T, Napoleon SC, Maynard M, Sosnowy C, Murphy M, Daley Ndoye C, Holcomb R, Schierberl Scherr A, Pinkston M, Chan PA.

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV

Alrubayyi A, Gea-Mallorquí E, Touizer E, Hameiri-Bowen D, Kopycinski J, Charlton B, Fisher-Pearson N, Muir L, Rosa A, Roustan C, Earl C, Cherepanov P, Pellegrino P, Waters L, Burns F, Kinloch S, Dong T, Dorrell L, Rowland-Jones S, McCoy L, Peppa D.

Minimizing the Impact of the Triple Burden of COVID-19, Tuberculosis and HIV on Health Services in sub-Saharan Africa

Nachega JB, Kapata N, Sam-Agudu NA, Decloedt EH, Katoto PDMC, Nagu T, Mwaba P, Yeboah-Manu D, Chanda-Kapata P, Ntoumi F, Geng EH, Zumla A.

Early combination treatment with existing HIV antivirals: an effective treatment for COVID-19?

Dallocchio RN, Dessì A, De Vito A, Delogu G, Serra PA, Madeddu G.

Coronavirus Occurrence in the HIVE Cohort of Michigan Households: Reinfection frequency and serologic responses to seasonal and SARS coronaviruses

Petrie JG, Bazzi LA, McDermott AB, Follmann D, Esposito D, Hatcher C, Mateja A, Narpala SR, O'Connell SE, Martin ET, Monto AS.

RNA sensors as a mechanism of innate immune evasion among SARS-CoV2, HIV and Nipah viruses

Dixon DCK, Ratan C, Nair B, Mangalath S, Abraham R, Nath LR.

Early Insights into COVID-19 in Persons Living with HIV and Cardiovascular Manifestations

Grant JK, Vincent L, Ebner B, Hurwitz BE, Alcaide ML, Martinez C.

Learning from HIV-1 to predict the immunogenicity of T cell epitopes in SARS-COV-2

Gao A, Chen Z, Amitai A, Doelger J, Mallajosyula V, Sundquist E, Segal FP, Carrington M, Davis MM, Streeck H, Chakraborty AK, Julg B.

Nurses at the frontline of public health emergency preparedness and response: lessons learned from the HIV/AIDS pandemic and emerging infectious disease outbreaks

Guilamo-Ramos V, Thimm-Kaiser M, Benzekri A, Hidalgo A, Lanier Y, Tlou S, de Lourdes Rosas López M, Soletti AB, Hagan H.

[1980-2020, from HIV to SARS-CoV-2, cycle change ?]

Deleuze J.

Short-Term Effects of the COVID-19 Pandemic on HIV Care Utilization, Service Delivery, and Continuity of HIV Antiretroviral Treatment (ART) in Haiti

Celestin K, Allorant A, Virgin M, Marinho E, Francois K, Honoré JG, White C, Valles JS, Perrin G, De Kerorguen N, Flowers J, Balan JG, Koama JBT, Barnhart S, Puttkammer N.

Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis

Ssentongo P, Heilbrunn ES, Ssentongo AE, Advani S, Chinchilli VM, Nunez JJ, Du P.

Enhanced Telehealth Case Management Plus Emergency Financial Assistance for Homeless-Experienced People Living With HIV During the COVID-19 Pandemic

Brody JK, Rajabiun S, Strupp Allen HJ, Baggett T.

Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infection

Copertino DC Jr, Casado Lima BC, Duarte RRR, Powell TR, Ormsby CE, Wilkin T, Gulick RM, de Mulder Rougvie M, Nixon DF.

In vitro characterization of engineered red blood cells as viral traps against HIV-1 and SARS-CoV-2

Hoffmann MAG, Kieffer C, Bjorkman PJ.

SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway

Campbell GR, To RK, Hanna J, Spector SA.

Tenofovir-based PrEP for COVID-19: an untapped opportunity?

DeJong C, Spinelli MA, Okochi H, Gandhi M.

Impact of the COVID-19-related global recession on the financing of the global HIV response

Bulstra CA, Reddy CL, Atun R, Bärnighausen T, Hontelez JAC.

The HIV Pandemic Prevention Efforts Can Inform the COVID-19 Pandemic Response in the United States

Carrasco MA, Atkins K, Young R, Rosen JG, Grieb SM, Wong VJ, Fleming PJ.

Mental Health, Coping, and Social Support Among People Living with HIV in the Americas: A Comparative Study Between Argentina and the USA During the SARS-CoV-2 Pandemic

Jones DL, Ballivian J, Rodriguez VJ, Uribe C, Cecchini D, Salazar AS, Cassetti I, Alcaide ML.

Sex Differences in the Association Between Stress, Loneliness, and COVID-19 Burden among People with HIV in the US

Jones DL, Rodriguez VJ, Salazar AS, Montgomerie E, Raccamarich PD, Uribe Starita C, Barreto Ojeda IT, Beauchamps L, Vazquez A, Martinez T, Alcaide ML.

COVID-19: Learning from the HIV/AIDS pandemic response in Africa

Olufadewa I, Oduguwa I, Adesina M, Ibiang K, Eke N, Adewumi B, Ebong I, Abudu F, Adeyelu N.

HIV testing by public health centers and municipalities and new HIV cases during the COVID-19 pandemic in Japan

Ejima K, Koizumi Y, Yamamoto N, Rosenberg M, Ludema C, Bento AI, Yoneoka D, Ichikawa S, Mizushima D, Iwami S.

How antiretroviral therapy (ART) programmes in Africa can maintain treatment for people living with HIV (PLHIV) during COVID-19 pandemic

Bekolo CE.

The fight against COVID-19 in sub-Saharan Africa-a threat to the continuous management of HIV patients: application of the action areas of the Ottawa charter for health promotion

Tarkang EE.

Darunavir/cobicistat is associated with negative outcomes in HIV-negative patients with severe COVID-19 pneumonia

Milic J, Novella A, Meschiari M, Menozzi M, Santoro A, Bedini A, Cuomo G, Franceschini E, Digaetano M, Carli F, Ciusa G, Volpi S, Bacca E, Franceschi G, Yaacoub D, Rogati C, Tutone M, Burastero G, Faltoni M, Iadisernia V, Dolci G, Cossarizza A, Mussini C, Pasina L, Guaraldi G.

Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization

Turner HL, Andrabi R, Cottrell CA, Richey ST, Song G, Callaghan S, Anzanello F, Moyer TJ, Abraham W, Melo M, Silva M, Scaringi N, Rakasz EG, Sattentau Q, Irvine DJ, Burton DR, Ward AB.

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV

Alrubayyi A, Gea-Mallorquí E, Touizer E, Hameiri-Bowen D, Kopycinski J, Charlton B, Fisher-Pearson N, Muir L, Rosa A, Roustan C, Earl C, Cherepanov P, Pellegrino P, Waters L, Burns F, Kinloch S, Dong T, Dorrell L, Rowland-Jones S, McCoy LE, Peppa D.

The potential effect of COVID-19-related disruptions on HIV incidence and HIV-related mortality among men who have sex with men in the USA: a modelling study

Mitchell KM, Dimitrov D, Silhol R, Geidelberg L, Moore M, Liu A, Beyrer C, Mayer KH, Baral S, Boily MC.

Same script, different viruses: HIV and COVID-19 in US Black communities

Fields EL, Copeland R, Hopkins E.

Call to action: how can the US Ending the HIV Epidemic initiative succeed?

Beyrer C, Adimora AA, Hodder SL, Hopkins E, Millett G, Mon SHH, Sullivan PS, Walensky RP, Pozniak A, Warren M, Richman B, Copeland R, Mayer KH.

The Impact of COVID-19 on HIV Care Provided via Telemedicine-Past, Present, and Future

Budak JZ, Scott JD, Dhanireddy S, Wood BR.

Perceptions of the Importance of Advance Care Planning During the COVID-19 Pandemic Among Older Adults Living With HIV

Nguyen AL, Davtyan M, Taylor J, Christensen C, Brown B.

Lopinavir/ritonavir: Repurposing an old drug for HIV infection in COVID-19 treatment

Magro P, Zanella I, Pescarolo M, Castelli F, Quiros-Roldan E.

COVID-19 Pandemic, Pre-exposure Prophylaxis (PrEP) Care, and HIV/STI Testing Among Patients Receiving Care in Three HIV Epidemic Priority States

Hill BJ, Anderson B, Lock L.

HIV and SARS-CoV-2 Co-infection: A Systematic Review of the Literature and Challenges

Patel RH, Acharya A, Chand HS, Mohan M, Byrareddy SN.

Impact of a COVID-19 National Lockdown on Integrated Care for Hypertension and HIV

Schwartz JI, Muddu M, Kimera I, Mbuliro M, Ssennyonjo R, Ssinabulya I, Semitala FC.

Covid-19: How the lessons of HIV can help end the pandemic

Arnold C.

Challenges facing users of hearing aids during the COVID-19 pandemic

Alqudah S, Zaitoun M, Alqudah O, Alqudah S, Alqudah Z.

Risk of adverse COVID-19 outcomes for people living with HIV: a rapid review and meta-analysis

Mellor MM, Bast AC, Jones NR, Roberts NW, Ordóñez-Mena JM, Reith AJM, Butler CC, Matthews PC, Dorward J.

PRESSING QUESTIONS AND CHALLENGES IN THE HIV-1 AND SARS-COV-2 SYNDEMIC

Montano M.

The impact of the COVID-19 pandemic on people living with HIV in Victoria, Australia

Weerasuria M, Ko C, Ehm A, O'Bryan J, McMahon JH, Woolley I, Hoy J, Lau J.

COVID-19 is viewed as severe as tumor and HIV; perceptions towards COVID-19

Menebo MM.

COVID-19 in a Patient Newly Diagnosed with AIDS: Asymptomatic Disease

Serrano Martins M, Pimentel F, Costa W, Fernandes C.

Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings

Lau JS, Rasmussen TA, Lewin SR, Ehm A, Martinez C, Burnett C, McMahon JH.

Indirect HIV morbidity and mortality due to COVID-19

Bell N, Bracchi M, Dalla Pria A, Nelson M, Boffito M.

Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic

Ferreira LMR, Mostajo-Radji MA.

An Interactive Voice Response Software to Improve the Quality of Life of People Living With HIV in Uganda: Randomized Controlled Trial

Byonanebye DM, Nabaggala MS, Naggirinya AB, Lamorde M, Oseku E, King R, Owarwo N, Laker E, Orama R, Castelnuovo B, Kiragga A, Parkes-Ratanshi R.

Antiretroviral Laboratory Monitoring and Implications for HIV Clinical Care in the Era of COVID-19 and Beyond

York L, Fisher JM, Malladi L, August JA, Ellis KE, Marquez JL, Kaveti A, Khachatryan M, Paz MK, Adams MD, Bedrick EJ, Fantry LE.

Black and Latino Persons Living with HIV Evidence Risk and Resilience in the Context of COVID-19: A Mixed-Methods Study of the Early Phase of the Pandemic

Gwadz M, Campos S, Freeman R, Cleland CM, Wilton L, Sherpa D, Ritchie AS, Hawkins RL, Allen JY, Martinez BY, Dorsen C, Collins LM, Hroncich T, Cluesman SR, Leonard NR.

Behavioral Response to HIV/AIDS Prevention Messages Among Students in Selected Universities of Amhara Region, Northwest Ethiopia: An Extended Parallel Process Model

Afenigus AD, Mulugeta H, Tsehay B, Gedfew M, Ayenew T, Getnet A.

HIV mRNA Vaccines-Progress and Future Paths

Mu Z, Haynes BF, Cain DW.

The screening and evaluation of potential clinically significant HIV drug combinations against the SARS-CoV-2 virus

Tomić D, Davidović D, Szasz AM, Rezeli M, Pirkić B, Petrik J, Vrca VB, Janđel V, Lipić T, Skala K, Mesarić J, Periša MM, Šojat Z, Rogina BM.

The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis

Dorward J, Khubone T, Gate K, Ngobese H, Sookrajh Y, Mkhize S, Jeewa A, Bottomley C, Lewis L, Baisley K, Butler CC, Gxagxisa N, Garrett N.

Consequences of COVID-19 crisis for persons with HIV: the impact of social determinants of health

Waterfield KC, Shah GH, Etheredge GD, Ikhile O.

Brazil sustains HIV response during the COVID-19 pandemic

Pereira GFM.

Dangerous liaisons? The role of inflammation and comorbidities in HIV and SARS-CoV-2 infection

Maggi P, Ricci E, Messina V, Salzillo A, Simeone F, Iodice A, Socio GV.

The impact of the SARS-CoV-2 pandemic on HIV and bacterial sexually transmitted infection testing and diagnosis in Oregon

Menza TW, Zlot AI, Garai J, Humphrey S, Ferrer J.

HIV pre-exposure prophylaxis in the time of COVID-19: How a robust and responsive HIV PrEP intervention can avert loss of HIV prevention coverage during a global pandemic

Saberi P, Ming K, Hojilla JC, Scott HM, Neilands TB.

Learning From the Past to Guide the Future: HIV and COVID-19

Chavez J, Worth K.

COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State

Tesoriero JM, Swain CE, Pierce JL, Zamboni L, Wu M, Holtgrave DR, Gonzalez CJ, Udo T, Morne JE, Hart-Malloy R, Rajulu DT, Leung SJ, Rosenberg ES.

Clinical characteristics and outcomes of people living with HIV hospitalized with COVID-19: a nationwide experience

Ceballos ME, Ross P, Lasso M, Dominguez I, Puente M, Valenzuela P, Enberg M, Serri M, Muñoz R, Pinos Y, Silva M, Noguera M, Dominguez A, Zamora F; Chilean HIV/COVID-19 Study Group.

High Level Stable Expression of Recombinant HIV gp120 in Glutamine Synthetase Gene Deficient HEK293T Cells

Zou Z, Wang R, Go EP, Desaire H, Sun PD.

Mitigating the impact of COVID-19 on tuberculosis and HIV services: A cross-sectional survey of 669 health professionals in 64 low and middle-income countries

Khan MS, Rego S, Rajal JB, Bond V, Fatima RK, Isani AK, Sutherland J, Kranzer K.

Mobile Health-Supported HIV Self-Testing Strategy Among Urban Refugee and Displaced Youth in Kampala, Uganda: Protocol for a Cluster Randomized Trial (Tushirikiane, Supporting Each Other)

Logie C, Okumu M, Hakiza R, Kibuuka Musoke D, Berry I, Mwima S, Kyambadde P, Kiera UM, Loutet M, Neema S, Newby K, McNamee C, Baral SD, Lester R, Musinguzi J, Mbuagbaw L.

Neurosyphilis and the Jarisch-Herxheimer Reaction: A Therapy Concern with HIV Disease

Kapila R, Schwartz RA.

Pandemics and pathology: a reflection on influenza, HIV/AIDS and SARS (COVID-19) pandemic infections

Lucas S.

Covid-19 could have disastrous impacts on HIV, TB and malaria

Vaughan A.

Projected HIV and Bacterial STI Incidence Following COVID-Related Sexual Distancing and Clinical Service Interruption

Jenness SM, Le Guillou A, Chandra C, Mann LM, Sanchez T, Westreich D, Marcus JL.

Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort

Nasreddine R, Florence E, Moutschen M, Yombi JC, Goffard JC, Derdelinckx I, Lacor P, Vandekerckhove L, Messiaen P, Vandecasteele S, Delforge M, De Wit S; Belgian Research on AIDS and HIV Consortium (BREACH).

Wave the Yellow Flag: Why we should prioritize routine HIV and STI care now

Eaton EF, Clement ME.

HIV prevention research and COVID-19: putting ethics guidance to the test

Rennie S, Chege W, Schrumpf LA, Luna F, Klitzman R, Moseki E, Brown B, Wakefield S, Sugarman J.

Do not repeat mistakes from HIV in COVID-19 response

The Lancet Hiv.

[Pneumocystis pneumonia and HIV infection in two patients suspected with COVID-19]

Borchmann O, Hansen AE.

[Dengue and SARS-CoV-2 coinfection in an HIV positive patient]

Salvo CP, Di Lella N, Solveyra López F, Hugo J, Gigena Zito J, Vilela A.

HIV testing during the COVID-19 pandemic

Filson SA, Rahim A, Parris V, McGregor A, Papineni P.

Harm Reduction and Adaptations Among PWUD in Rural Oregon During COVID-19

Seaman A, Leichtling G, Stack E, Gray M, Pope J, Larsen JE, Leahy JM, Gelberg L, Korthuis PT.

Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review

Naidoo N, Moodley J, Naicker T.

SARS-CoV-2 and Advanced HIV Infection

Choy CY, Wong CS.

COVID-19 restrictions and changing sexual behaviours in HIV-negative MSM at high risk of HIV infection in London, UK

Hyndman I, Nugent D, Whitlock GG, McOwan A, Girometti N.

Perceived interruptions to HIV prevention and treatment services associated with COVID-19 for gay, bisexual, and other men who have sex with men in 20 countries

Rao A, Rucinski K, Jarrett B, Ackerman B, Wallach S, Marcus J, Adamson T, Garner A, Santos GM, Beyrer C, Howell S, Baral S.

[HIV in the time of COVID-19 : the meeting between two pandemics]

Nawej Tshikung O, Buvelot H, Calmy A, Cavassini M.

Enfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor: an in silico drug repurposing study

Ahmadi K, Farasat A, Rostamian M, Johari B, Madanchi H.

A systematic review of contemporary evidence on SARS-CoV-2 and HIV coinfection: What does it look like up to date?

Shareef MA, Bashaiwth HM, AlAkbari AO, Bahamran MS, AlAmodi MO, Albaiti SH, Ali MA, Eshaq AM, Alkattan K, Alamodi AA.

Similarities and differences between HIV and SARS-CoV-2

Illanes-Álvarez F, Márquez-Ruiz D, Márquez-Coello M, Cuesta-Sancho S, Girón-González JA.

Clinical Outcomes and Inflammatory Markers by HIV Serostatus and Viral Suppression in a Large Cohort of Patients Hospitalized With COVID-19

Patel VV, Felsen UR, Fisher M, Fazzari MJ, Ginsberg MS, Beil R, Akiyama MJ, Anastos K, Hanna DB.

22(4):227-228. doi: 10.24875/AIDSRev.M20000039.","Soriano V","AIDS Rev","2020","2021/01/05","","","10.24875/AIDSRev.M20000039"

21(1):1167. doi: 10.4102/sajhivmed.v21i1.1167. eCollection 2020.","Elsayed H","South Afr J HIV Med","2020","2021/01/04","PMC7756945","","10.4102/sajhivmed.v21i1.1167"

Maintaining ART services during COVID-19 border closures: lessons learned in Namibia

Hans L, Hong SY, Ashipala LSN, Bikinesi L, Hamunime N, Kamangu JWN, Hatutale EJ, Dziuban EJ.

HIV and SARS-CoV-2 co-infection: cross-sectional findings from a German 'hotspot'

Noe S, Schabaz F, Heldwein S, Mayer W, Ruecker K, Tiller FW, von Krosigk A, Wiese C, Balogh A, Gersbacher E, Jonsson-Oldenbuettel C, Jaeger H, Wolf E; ArcHIV study group..

European Union, HIV, and Coronavirus Disease 2019 (COVID-19): Progress and Lessons Learned From the HIV Pandemic

Granich R, Gupta S.

Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System

Peng X, Ouyang J, Isnard S, Lin J, Fombuena B, Zhu B, Routy JP.

Editorial - HIV and cancer during COVID-19 pandemic: sailing through the perfect storm

De Vito A, Madeddu G.

Immune deficiency is a risk factor for severe COVID-19 in people living with HIV

Hoffmann C, Casado JL, Härter G, Vizcarra P, Moreno A, Cattaneo D, Meraviglia P, Spinner CD, Schabaz F, Grunwald S, Gervasoni C.

Preparing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Self-Testing Implementation: Lessons Learned From HIV Self-Testing

Conserve DF, Mathews A, Choko AT, Nelson LE.

Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2

Park KS, Bazzill JD, Son S, Nam J, Shin SW, Ochyl LJ, Stuckey JA, Meagher JL, Chang L, Song J, Montefiori DC, LaBranche CC, Smith JL, Xu J, Moon JJ.

COVID-19 crisis effect on HIV service delivery in Egypt: Hard times or blessings in disguise?

Mohamed R, Wanis H, Zebachi S, El-Kotamy MT, Esmat G, Cordie A.

Racial/ethnic and Income Disparities in the Prevalence of Comorbidities that Are Associated With Risk for Severe COVID-19 Among Adults Receiving HIV Care, United States, 2014-2019

Weiser JK, Tie Y, Beer L, Fanfair RN, Shouse RL.

The Unpredictable Outcome of SARS-CoV-2 in Kidney Transplant Recipients With HIV-infection

de Sandes-Freitas TV, Cristelli MP, Neri BO, Guedes ALMO, Esmeraldo RM, Garcia VD, Dal Prá RL, Suassuna JHR, Rioja SDS, Zanocco JA, Claudino AB, Medina-Pestana JO, Tedesco-Silva H.

HIV testing and diagnoses during the COVID-19 pandemic in Melbourne, Australia

Chow EPF, Ong JJ, Denham I, Fairley CK.

Preparedness of health facilities providing HIV services during COVID-19 pandemic and assessment of their compliance to COVID-19 prevention measures: findings from the Tanzania Service Provision Assessment (SPA) survey

Bajaria S, Abdul R.

Pragmatic randomized trial of a pre-visit intervention to improve the quality of telemedicine visits for vulnerable patients living with HIV

Hickey MD, Sergi F, Zhang K, Spinelli MA, Black D, Sola C, Blaz V, Nguyen JQ, Oskarsson J, Gandhi M, Havlir DV.

HIV care models during the COVID-19 era

Guaraldi G, Milic J, Martinez E, Kamarulzaman A, Mussini C, Waters L, Pozniak A, Mallon P, Rockstroh J, Lazarus JV.

COVID-19 epidemic in the US-A gateway to screen for tuberculosis, HIV, viral hepatitides, Chagas disease, and other neglected tropical diseases among Hispanics

Schultz J, Hyson P, Chastain DB, Gharamti AA, Franco-Paredes C, Henao-Martínez AF.

The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease - a report from Central and Eastern Europe

Kowalska JD, Kase K, Vassilenko A, Harxhi A, Lakatos B, Lukić GD, Verhaz A, Yancheva N, Dumitrescu F, Jilich D, Machala L, Skrzat-Klapaczyńska A, Matulionyte R.

HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform

Bhaskaran K, Rentsch CT, MacKenna B, Schultze A, Mehrkar A, Bates CJ, Eggo RM, Morton CE, Bacon SCJ, Inglesby P, Douglas IJ, Walker AJ, McDonald HI, Cockburn J, Williamson EJ, Evans D, Forbes HJ, Curtis HJ, Hulme WJ, Parry J, Hester F, Harper S, Evans SJW, Smeeth L, Goldacre B.

COVID-19 death in people with HIV: interpret cautiously

Waters LJ, Pozniak AL.

HIV cure research in the time of COVID-19 - antiretroviral therapy treatment interruption trials: a discussion paper

Fidler S, Lewin S, Deeks S, Sogaard OS, Vanderkerckhove L, Collins S, Kelly D, Singh J, Caskey M, Frater J.

Pay to skip the line: The political economy of digital testing services for HIV and other sexually transmitted infections

MacKinnon KR, Mykhalovskiy E, Worthington C, Gómez-Ramírez O, Gilbert M, Grace D.

Viral suppression not decreased during COVID-19 among people with HIV and unstable housing enrolled in a low-barrier clinic-based program (POP-UP)

Hickey MD, Imbert E, Glidden DV, Rosario JBD, Chong M, Clemenzi-Allen A, Oskarsson J, Riley ED, Gandhi M, Havlir DV.

Feasibility of Rapidly Developing and Widely Disseminating Patient Decision Aids to Respond to Urgent Decisional Needs due to the COVID-19 Pandemic

Stacey D, Ludwig C, Archambault P, Babulic K, Edwards N, Lavoie J, Sinha S, O'Connor AM.

Financial, Food, and Housing Insecurity Due to Coronavirus Disease 2019 Among At-Risk People With Human Immunodeficiency Virus in a Nonurban Ryan White HIV/AIDS Program Clinic

Sherbuk JE, Williams B, McManus KA, Dillingham R.

High acceptability of PrEP teleconsultation and HIV self-test among PrEP users during the COVID-19 pandemic in Brazil

Hoagland B, Torres TS, Bezerra DRB, Benedetti M, Pimenta C, Veloso VG, Grinsztejn B.

Detection of RNA viruses from influenza and HIV to Ebola and SARS-CoV-2: a review

Bukasov R, Dossym D, Filchakova O.

COVID-19 threatens HIV care continuity in Brazil

Daniels JP.

Changes in HIV preexposure prophylaxis prescribing in Australian clinical services following COVID-19 restrictions

Traeger MW, Patel P, Guy R, Hellard ME, Stoové MA; Australian Collaboration for Coordinated Enhanced Sentinel Surveillance (ACCESS).

Centring adolescent girls and young women in the HIV and COVID-19 responses

Goga A, Bekker LG, Van de Perre P, El-Sadr W, Ahmed K, Malahleha M, Ramraj T, Ramokolo V, Magasana V, Gray G.

The course of COVID-19 in four patients with HIV during the pandemic

Turken M, Altan H, Atalay S, Kose S.

Potential role of GcMAF in suppressing the severity of COVID-19-induced immune responses: Lesson learned from HIV

Spadera L, Spadera M.

COVID-19 infection among people with HIV in New York City: A population-level analysis of linked surveillance data

Braunstein SL, Lazar R, Wahnich A, Daskalakis DC, Blackstock OJ.

Caring for people living with HIV during the global COVID-19 pandemic

Tshikung ON, Smit M, Marinosci A, Buvelot H, Valladares P, Do-Co Lecompte T, Flammer Y, Calmy A.

Maintaining the HIV response in a world shaped by COVID-19

The Lancet.

Antiretroviral treatment interruption among people living with HIV during COVID-19 outbreak in China: a nationwide cross-sectional study

Sun Y, Li H, Luo G, Meng X, Guo W, Fitzpatrick T, Ao Y, Feng A, Liang B, Zhan Y, Sande A, Xie F, Wang Y, Qian HZ, Cai Y, Zou H.

COVID-19 & HIV/AIDS pandemics: Parallels & lessons

Dawa N, Narain JP.

Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020

Simões D, Stengaard AR, Combs L, Raben D; EuroTEST COVID-19 impact assessment consortium of partners.

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2's main protease

Mahdi M, Mótyán JA, Szojka ZI, Golda M, Miczi M, Tőzsér J.

Challenges to HIV service delivery and the impacts on patient care during COVID-19: perspective of HIV care providers in Guangxi, China

Qiao S, Yang X, Sun S, Li X, Mi T, Zhou Y, Shen Z.

Marking World AIDS Day in a COVID-19 world

Peate I.

Managing the COVID-19 Pandemic: Biopsychosocial Lessons Gleaned From the AIDS Epidemic

Halkitis PN.

Mental health, coping, and social support among people living with HIV in the Americas: A comparative study between Argentina and the USA during the SARS-CoV-2 pandemic

Jones DL, Ballivian J, Rodriguez VJ, Uribe C, Cecchini D, Salazar AS, Cassetti I, Alcaide ML.

COVID-19 antibody development fueled by HIV-1 broadly neutralizing antibody research

Mendoza P, Lorenzi JCC, Gaebler C.

New pathogen, same disparities: why COVID-19 and HIV remain prevalent in U.S. communities of colour and implications for ending the HIV epidemic

Millett GA.

COVID-19 symptoms and SARS-CoV-2 infection among people living with HIV in the US: the MACS/WIHS combined cohort study

D'Souza G, Springer G, Gustafson D, Kassaye S, Alcaide ML, Ramirez C, Sharma A, Palella FJ, Tien PC, Detels R, Kempf MC, Lahiri CD, Rinaldo CR, French AL, Margolick JB, Adimora AA.

A High Percentage of People with HIV on Antiretroviral Therapy Experience Detectable Low-Level Plasma HIV-1 RNA Following COVID-19

Peluso MJ, Bakkour S, Busch MP, Deeks SG, Henrich TJ.

Using decision aids to support self-isolation during the COVID-19 pandemic

Lunn PD, Timmons S, Julienne H, Belton CA, Barjaková M, Lavin C, McGowan FP.

Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infection with HIV: clinical case series analysis in North Central Nigeria

Akyala AI, Iwu CJ.

Aligning diagnostics to the point-of-care: lessons for innovators, evaluators and decision-makers from tuberculosis and HIV

Engel N, Wolffs PFG.

High HIV prevalence in an early cohort of hospital admissions with COVID-19 in Cape Town, South Africa

Parker A, Koegelenberg CFN, Moolla MS, Louw EH, Mowlana A, Nortjé A, Ahmed R, Brittain N, Lalla U, Allwood BW, Prozesky H, Schrueder N, Taljaard JJ.

COVID-19 in HIV infected patients: A Case series and Literature Review

Swaminathan N, Moussa P, Mody N, Bryan Lo K, Pattaroyo GA.

Pneumocystis pneumonia, a COVID-19 mimic, reminds us of the importance of HIV testing in COVID-19

Kelly S, Waters L, Cevik M, Collins S, Lewis J, Wu MS, Blanchard TJ, Geretti AM.

COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living with HIV

Bogart LM, Ojikutu BO, Tyagi K, Klein DJ, Mutchler MG, Dong L, Lawrence SJ, Thomas D, Kellman S.

Seroprevalence of anti-SARS-CoV2 Antibodies in Umbrian Persons Living with HIV

Papalini C, Paciosi F, Schiaroli E, Pierucci S, Busti C, Bozza S, Mencacci A, Francisci D.

The interplay between HIV and COVID-19: summary of the data and responses to date

Brown LB, Spinelli MA, Gandhi M.

Adaptation of advanced clinical virology assays from HIV-1 to SARS-CoV-2

McCormick KD, Mellors JW, Jacobs JL.

Coronavirus Disease 2019 (COVID-19) in a Patient with Disseminated Histoplasmosis and HIV-A Case Report from Argentina and Literature Review

Messina FA, Marin E, Caceres DH, Romero M, Depardo R, Priarone MM, Rey L, Vázquez M, Verweij PE, Chiller TM, Santiso G.

Experience of SARS-CoV-2 infection in two kidney transplant recipients living with HIV-1 infection

Chowdary P, Shetty S, Booth J, Khurram M, Yaqoob M, Mohamed I.

Elevated COVID-19 outcomes among persons living with diagnosed HIV infection in New York State: Results from a population-level match of HIV, COVID-19, and hospitalization databases

Tesoriero JM, Swain CE, Pierce JL, Zamboni L, Wu M, Holtgrave DR, Gonzalez CJ, Udo T, Morne JE, Hart-Malloy R, Rajulu DT, Leung SJ, Rosenberg ES.

Estimating the potential impact of COVID-19-related disruptions on HIV incidence and mortality among men who have sex with men in the United States: a modelling study

Mitchell KM, Dimitrov D, Silhol R, Geidelberg L, Moore M, Liu A, Beyrer C, Mayer KH, Baral S, Boily MC.

Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium

Mehta SA, Rana MM, Motter JD, Small CB, Pereira MR, Stosor V, Elias N, Haydel B, Florman S, Odim J, Morsheimer M, Robien M, Massie AB, Brown D, Boyarsky B, Garonzik Wang J, Tobian AAR, Werbel WA, Segev DL, Durand CM; HOPE in Action Investigators..

The COVID-19 pandemic as a catalyst for differentiated care models to end the HIV epidemic in the U.S. - applying lessons from high-burden settings

Collins LF, Colasanti JA, Nguyen ML, Moran CA, Lahiri CD, Marconi VC, Armstrong WS, Shah NS.

The single-cell landscape of immunological responses of CD4+ T cells in HIV versus severe acute respiratory syndrome coronavirus 2

Collora JA, Liu R, Albrecht K, Ho YC.

The first 6 months of HIV-SARS-CoV-2 coinfection: outcomes for 6947 individuals

Johnston R.

COVID-19 in HIV: a Review of Published Case Reports

Morani Z, Patel S, Ghosh S, Hassan FA, Doreswamy S, Singh S, Kothapudi VN, Desai R.

Telemedicine Aids in Initial Deep Brain Stimulation Programming for Dystonia

Prakash N, Zadikoff C.

Persons with HIV and the COVID-19 Pandemic: A Viral Synergy of Biology and Sociology

Collins LF.

COVID-19-Associated Histoplasmosis in an AIDS Patient

Basso RP, Poester VR, Benelli JL, Stevens DA, Zogbi HE, Vasconcellos ICDS, Pasqualotto AC, Xavier MO.

Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus

Prashantha CN, Gouthami K, Lavanya L, Bhavanam S, Jakhar A, Shakthiraju RG, Suraj V, Sahana KV, Sujana HS, Guruprasad NM, Ramachandra R.

Physical and mental health screening in a New York City HIV cohort during the COVID-19 pandemic: A preliminary report

Pizzirusso M, Carrion-Park C, Clark US, Gonzalez J, Byrd D, Morgello S.

HIV and SARS-CoV-2: points to consider to face this new pandemic

Prieto Pozo AA, Salvador Sagüez FLD.

Vulnerability to COVID-19-related Harms Among Transgender Women With and Without HIV Infection in the Eastern and Southern U.S

Poteat TC, Reisner SL, Miller M, Wirtz AL.

Impact of COVID-19-Related Stress and Lockdown on Mental Health Among People Living With HIV in Argentina

Ballivian J, Alcaide ML, Cecchini D, Jones DL, Abbamonte JM, Cassetti I.

Online pharmacy navigation skills are associated with prospective memory in HIV disease

Matchanova A, Woods SP, Cushman C, Morgan EE, Medina LD, Babicz MA, Verduzco M, Loft S.

Mental Health Problems of HIV Healthcare Providers During the COVID-19 Pandemic: The Interactive Effects of Stressors and Coping

Mi T, Yang X, Sun S, Li X, Tam CC, Zhou Y, Shen Z.

COVID-19 DISEASE IN PEOPLE LIVING WITH HIV: A MULTICENTER CASE-SERIES STUDY

Cabello A, Zamarro B, Nistal S, Victor V, Hernández J, Prieto-Pérez L, Carrillo I, Álvarez B, Fernández-Roblas R, Hernández-Segurado M, Becares J, Benito JM, Rallón N, Téllez R, Castaño ÁL, Herrero A, Górgolas M.

Not Remembering History, Dooms Us to Repeat It: Using the Lessons of the Global HIV Response to Address COVID-19

Rotheram-Borus MJ, Tomlinson M.

AIDS and COVID-19: more lessons to be learned

Whiteside A, van Wyngaard A.

COVID-19, HIV and key populations: cross-cutting issues and the need for population-specific responses

Iversen J, Sabin K, Chang J, Morgan Thomas R, Prestage G, Strathdee SA, Maher L.

HIV Prevention and Treatment in the Context of the COVID-19 in the Bronx, New York: Implications for Practice and Research

Patel VV, Beil R, Slawek D, Akiyama MJ.

Continuity of HIV Care in the Presence of COVID-19

Zuniga JM.

SARS-CoV-2 and HIV: Epidemiology, Treatment, and Lessons Learned from HIV

Castel AD, Wilbourn B, Magnus M, Greenberg AE.

The Risk and Impact of COVID-19 Pandemic on Immunosuppressed Patients: Cancer, HIV, and Solid Organ Transplant Recipients

Mohammed AH, Blebil A, Dujaili J, Rasool-Hassan BA.

It's complicated: A case report on a COVID-19-positive HIV patient presenting with rhabdomyolysis and acute kidney injury

Foster A, Khan Z, Siddiqui A, Singh S, Atere M, Nfonoyim JM.

Test@Work Texts: Mobile Phone Messaging to Increase Awareness of HIV and HIV Testing in UK Construction Employees during the COVID-19 Pandemic

Middleton M, Somerset S, Evans C, Blake H.

Concerns of HIV-positive migrant workers in COVID-19 pandemic: A call for action

Ahmed A, Dujaili J, Sandhu AK, Hashmi FK.

Knowledge, Attitude, and Practice Towards COVID-19 Among People Living with HIV/AIDS in Kigali, Rwanda

Iradukunda PG, Pierre G, Muhozi V, Denhere K, Dzinamarira T.

COVID-19 and preventative medicine for HIV infected children

Anderson L, Caniza M.

Self-medication practice with analgesics (NSAIDs and Acetaminophen), and antibiotics among nursing undergraduates in University College Farasan Island, Jazan University, KSA

Faqihi AMA, Sayed SF.

The burden of anxiety among people living with HIV during the COVID-19 pandemic in Pune, India

Marbaniang I, Sangle S, Nimkar S, Zarekar K, Salvi S, Chavan A, Gupta A, Suryavanshi N, Mave V.

Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study

Geretti AM, Stockdale AJ, Kelly SH, Cevik M, Collins S, Waters L, Villa G, Docherty A, Harrison EM, Turtle L, Openshaw PJM, Baillie JK, Sabin CA, Semple MG.

Comparing the AIDS and COVID-19 Pandemics Using the 5B Documentary

Manning ML.

Rapid Adaptation of HIV Treatment Programs in Response to COVID-19 - Namibia, 2020

Hong SY, Ashipala LSN, Bikinesi L, Hamunime N, Kamangu JWN, Boylan A, Sithole E, Pietersen IC, Mutandi G, McLean C, Dziuban EJ.

Psychological Distress Among HIV Healthcare Providers During the COVID-19 Pandemic in China: Mediating Roles of Institutional Support and Resilience

Tam CC, Sun S, Yang X, Li X, Zhou Y, Shen Z.

Understanding the impact of interruptions to HIV services during the COVID-19 pandemic: A modelling study

Jewell BL, Smith JA, Hallett TB.

Estimating the impact of disruptions due to COVID-19 on HIV transmission and control among men who have sex with men in China

Booton RD, Fu G, MacGregor L, Li J, Ong JJ, Tucker JD, Turner KM, Tang W, Vickerman P, Mitchell K.

Assessment of mental health outcomes and associated factors among workers in community-based HIV care centers in the early stage of the COVID-19 outbreak in Mali

Sagaon-Teyssier L, Kamissoko A, Yattassaye A, Diallo F, Rojas Castro D, Delabre R, Pouradier F, Maradan G, Bourrelly M, Cissé M, Vidal L, Dembélé Keïta B, Spire B.

Impact of COVID-19 on people with HIV: A Review

Prabhu S, Poongulali S, Kumarasamy N.

Diagnoses of syphilis and HIV infection during the COVID-19 pandemic in Taiwan

Chia CC, Chao CM, Lai CC.

Exploring anti-corruption, transparency, and accountability in the World Health Organization, the United Nations Development Programme, the World Bank Group, and the Global Fund to Fight AIDS, Tuberculosis and Malaria

Kohler JC, Bowra A.

Virologic and immunologic outcomes for HIV patients with coronavirus disease 2019

Hu R, Yan H, Liu M, Tang L, Kong W, Zhu Z, Liu P, Bai W, Hu X, Ding J, Wang X, Xie N.

New HIV diagnoses in patients with COVID-19: two case reports and a brief literature review

Zhang JC, Yu XH, Ding XH, Ma HY, Cai XQ, Kang SC, Xiang DW.

Clinical characteristics of COVID-19 patients with HIV coinfection in Wuhan, China

Yang R, Gui X, Zhang Y, Xiong Y, Gao S, Ke H.

COVID-19 Lockdown in Indonesia: Greater Investment Will Be Needed to Mitigate the Impact on People Living With HIV

Gedela K, Januraga PP, Luis H, Wignall FS, Irwanto I.

COVID-19 OUTCOMES IN PATIENTS WITH UNCONTROLLED HIV-1 INFECTION

Calza L, Bon I, Borderi M, Colangeli V, Borioni A, Re MC, Viale P.

Virtual HIV pre-exposure prophylaxis outpatient service in the era of COVID-19

Quirke S, Quinn L, Hegarty D, Loy A, Lyons F, Mulcahy F, Devitt E.

[Simultaneous diagnosis and favorable evolution of infection with Pneumocystis jirovecii, SARS-CoV-2 and advanced HIV]

Larzábal FJ, Vilela A, Brusca S, Saluzzi I, Ghergo GE, Angiono MA.

Implications of COVID-19 for HIV Research: data sources, indicators and longitudinal analyses

Rebeiro PF, Duda SN, Wools-Kaloustian KK, Nash D, Althoff KN; International epidemiology Databases to Evaluate AIDS (IeDEA).

Ensuring retention in care for people living with HIV during the COVID-19 pandemic in Rome, Italy

Giuliani M, Donà MG, La Malfa A, Pasquantonio MS, Pimpinelli F, Cristaudo A, Latini A.

Antibody response to SARS-CoV-2 in people living with HIV

Yamamoto S, Saito M, Nagai E, Toriuchi K, Nagai H, Yotsuyanagi H, Nakagama Y, Kido Y, Adachi E.

The First Case of an HIV Patient Diagnosed with COVID-19 in Korea

Kim JY, Kim JM, Peck KR.

The potential epidemiological impact of COVID-19 on the HIV/AIDS epidemic and the cost-effectiveness of linked, opt-out HIV testing: A modeling study in six US cities

Zang X, Krebs E, Chen S, Piske M, Armstrong WS, Behrends CN, Del Rio C, Feaster DJ, Marshall BDL, Mehta SH, Mermin J, Metsch LR, Schackman BR, Strathdee SA, Nosyk B.

COVID-19 Susceptibility and Outcomes among People Living with HIV in San Francisco

Sachdev D, Mara E, Hsu L, Scheer S, Rutherford G, Enanoria W, Gandhi M.

Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence

Tamuzi JL, Ayele BT, Shumba CS, Adetokunboh OO, Uwimana-Nicol J, Haile ZT, Inugu J, Nyasulu PS.

Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics

Saleemi MA, Ahmad B, Benchoula K, Vohra MS, Mea HJ, Chong PP, Palanisamy NK, Wong EH.

Innovations in HIV care delivery during the COVID-19 pandemic: Policies to strengthen the Ending the Epidemic Initiative - A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association

Armstrong WS, Agwu AL, Barrette EP, Ignacio RB, Chang JJ, Colasanti JA, Floris-Moore M, Haddad M, MacLaren L, Weddle A.

Unsafe Supply: Why Making Controlled Prescription Drugs Available for Unsupervised Use Will Not Target the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19-- A Commentary on Bonn et al. (2020)

Lembke A.

Addressing the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19 Among People Who Use Drugs: The Potential Roles for Decriminalization and Safe Supply

Bonn M, Palayew A, Bartlett S, Brothers TD, Touesnard N, Tyndall M.

Covid-19, Ebola, and HIV - Leveraging Lessons to Maximize Impact

Celum C, Barnabas R, Cohen MS, Collier A, El-Sadr W, Holmes KK, Johnston C, Piot P.

What the HIV Pandemic Experience can Teach the U.S. about the COVID-19 Response

Strathdee SA, Martin NK, Pitpitan EV, Stockman JK, Smith DM.

Substantial decline in use of HIV pre-exposure prophylaxis (PrEP) following introduction of COVID-19 physical distancing restrictions in Australia: Results from a prospective observational study of gay and bisexual men

Hammoud MA, Grulich A, Holt M, Maher L, Murphy D, Jin F, Bavinton B, Haire B, Ellard J, Vaccher S, Saxton P, Bourne A, Degenhardt L, Storer D, Prestage G.

From HIV to COVID-19: Focusing on and Engaging Adolescents and Young Adults During the Pandemic

DeLong SM, Denison JA, Yang C, Agwu A, Alexander KA, Kaufman MR, Arrington-Sanders R.

Projected HIV and Bacterial STI Incidence Following COVID-Related Sexual Distancing and Clinical Service Interruption

Jenness SM, Le Guillou A, Chandra C, Mann LM, Sanchez T, Westreich D, Marcus JL.

COVID-19 plus HIV: Risiken für schwere Verläufe : Koinfektionen

Starostzik C.

Wise Use of Surveillance Data: Evolving HIV Policy and Emerging Considerations Regarding COVID-19

Seiler N, Horton K, Vanecek A, Heyison C.

Ethical Convergence and Ethical Possibilities: The Implications of New Materialism for Understanding the Molecular Turn in HIV, the Response to COVID-19, and the Future of Bioethics

Guta A, Gagnon M, Philbin MM.

Computational Evaluation of the Inhibition Efficacies of HIV Antivirals on SARS-CoV-2 (COVID-19) Protease and Identification of 3D Pharmacophore and Hit Compounds

Raphael VP, Shanmughan SK.

COVID-19 and VIH

Posada-Vergara MP, Alzate-Ángel JC, Martínez-Buitrago E.

Learning from combination HIV prevention programmes to face COVID-19 emerging pandemic

Palacios R, Mathias A.

Consequences of the COVID-19 pandemic on the continuum of care in a cohort of people living with HIV followed in a single center of Northern Italy

Quiros-Roldan E, Magro P, Carriero C, Chiesa A, El Hamad I, Tratta E, Fazio R, Formenti B, Castelli F.

Leveraging the advances in HIV for COVID-19

McMahon JH, Hoy JF, Kamarulzaman A, Bekker LG, Beyrer C, Lewin SR.

A Cross-Sectional Analysis of Tobacco Use and Concurrent Alcohol and Substance Use Among Patients Living with HIV/HCV Co-infection: Findings from a Large Urban Tertiary Center

Sims OT, Jackson A, Guo Y, Truong DN, Odame EA, Mamudu HM.

Adapting HIV services for pregnant and breastfeeding women, infants, children, adolescents and families in resource-constrained settings during the COVID-19 pandemic

Vrazo AC, Golin R, Fernando NB, Killam WP, Sharifi S, Phelps BR, Gleason MM, Wolf HT, Siberry GK, Srivastava M.

Insult to injury- potential contribution of COVID-19 to neuroinflammation and the development of HIV-associated neurocognitive disorders

Williams ME, Fielding BC.

SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital

Isernia V, Julia Z, Le Gac S, Bachelard A, Landman R, Lariven S, Joly V, Deconinck L, Rioux C, Lescure X, Yazdanpanah Y, Ghosn J.

COVID-19 in an HIV-infected patient. Lessons learned from an autopsy case

Khaba MC, Ngale TC, Madala N.

Maintaining robust HIV and TB services in the COVID-19 era: A public health dilemma in Zimbabwe

Mukwenha S, Dzinamarira T, Mugurungi O, Musuka G.

Community action for people with HIV and sex workers during the COVID-19 pandemic in India

Reza-Paul S, Lazarus L, Haldar P, Reza Paul M, Lakshmi B, Ramaiah M, Pasha A, Hafeez Ur Rahman S, Venukumar KT, Venugopa MS, Rewari BB, Lorway R.

COVID-19 in people living with HIV: clinical implications of dynamics of immune response to SARS-CoV-2

Mondi A, Cimini E, Colavita F, Cicalini S, Pinnetti C, Matusali G, Casetti R, Maeurer M, Vergori A, Mazzotta V, Gagliardini R, De Zottis F, Schininà V, Girardi E, Puro V, Ippolito G, Vaia F, Capobianchi MR, Castilletti C, Agrati C, Antinori A.

HIV care during the coronavirus disease-2019 pandemic in Shenzhen, China

Wang H.

Early impact of COVID-19 social distancing measures on reported sexual behaviour of HIV pre-exposure prophylaxis users in Wales

Gillespie D, Knapper C, Hughes D, Couzens Z, Wood F, de Bruin M, Ma R, Jones AT, Williams A, Hood K.

Core Elements of a National COVID-19 Strategy: Lessons Learned from the US National HIV/AIDS Strategy

Holtgrave DR, Valdiserri RO, Kalichman SC, Del Rio C, Thompson M.

HIV testing amid COVID-19: community efforts to reach men who have sex with men in three Kenyan counties

Odinga MM, Kuria S, Muindi O, Mwakazi P, Njraini M, Melon M, Kombo B, Kaosa S, Kioko J, Musimbi J, Musyoki H, Bhattacharjee P, Lorway R.

Sharing Experiences and Lessons: Medical Issues in Confronting the HIV Epidemic and COVID-19

Volberding P.

Virtual CROI 2020: Tuberculosis and Coinfections In HIV Infection

Kerkhoff AD, Havlir DV.

Studying the neuropsychological sequelae of SARS-CoV-2: lessons learned from 35 years of neuroHIV research

Levine A, Sacktor N, Becker JT.

Picture of a pandemic: visual aids in the COVID-19 crisis

Hamaguchi R, Nematollahi S, Minter DJ.

Sex in the Time of COVID-19: Results of an Online Survey of Gay, Bisexual and Other Men Who Have Sex with Men's Experience of Sex and HIV Prevention During the US COVID-19 Epidemic

Stephenson R, Chavanduka TMD, Rosso MT, Sullivan SP, Pitter RA, Hunter AS, Rogers E.

Opioid and neuroHIV Comorbidity - Current and Future Perspectives

Fitting S, McRae M, Hauser KF.

Models of service delivery for optimizing a patient's first six months on antiretroviral therapy for HIV: an applied research agenda

Rosen S, Grimsrud A, Ehrenkranz P, Katz I.

COVID-19 pneumonia in an HIV-positive woman on antiretroviral therapy and undetectable viral load in Porto Alegre, Brazil

Cipolat MM, Sprinz E.

COVID-19 in Hospitalized Adults With HIV

Stoeckle K, Johnston CD, Jannat-Khah DP, Williams SC, Ellman TM, Vogler MA, Gulick RM, Glesby MJ, Choi JJ.

Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors

Cardoso WB, Mendanha SA.

HIV and Human Coronavirus Coinfections: A Historical Perspective

Makoti P, Fielding BC.

Disparity in HIV Service Interruption in the Outbreak of COVID-19 in South Carolina

Qiao S, Li Z, Weissman S, Li X, Olatosi B, Davis C, Mansaray AB.

Fatal case of HIV and COVID-19

Elhadi M, Momen AA, Ali Senussi Abdulhadi OM, Msherghi A.

Predisposition or Protection?: COVID-19 in a Patient on LVAD Support With HIV/AIDS

Mahmood K, Rashed ER, Oliveros E, Chau VQ, Hermle T, Jacobs S, Lala A, Singhvi A, Parikh A, Pinney SP.

HIV and shifting epicenters for COVID-19, an alert for some countries

Doungmo Goufo EF, Khan Y, Chaudhry QA.

Human Immunodeficiency Virus: A Dark Cloud With Silver Lining During the COVID-19 Pandemic

Pata RK, Ahmady A, Kiani R.

Antiretroviral therapy optimisation in the time of COVID-19: Is it really different in North and South Africa?

Cordie A, El-Kotamy MT, Esmat G.

Prognosis of coronavirus disease 2019 (COVID-19) in patients with HIV infection in New York City

Miyashita H, Kuno T.

Impact of the COVID-19 pandemic on the medical follow-up and psychosocial well-being of people living with HIV: A cross-sectional survey

Siewe Fodjo JN, Faria de Moura Villela E, Van Hees S, Tibério Dos Santos T, Vanholder P, Vanholder P, Reyntiens P, Van den Bergh R, Colebunders R.

The Burden of Anxiety During the COVID-19 Pandemic Among People Living with HIV (PLHIV) in Pune, India

Marbaniang I, Sangle S, Nimkar S, Zarekar K, Salvi S, Chavan A, Gupta A, Suryavanshi N, Mave V.

The Diagnostic Trap Occurred in Two COVID-19 Cases Combined Pneumocystis Pneumonia in Patient with AIDS

Guo W, Wang M, Ming F, Tang W, Liang K.

A rapid qualitative assessment of the impact of the COVID-19 pandemic on a racially/ethnically diverse sample of gay, bisexual, and other men who have sex with men living with HIV in the US South

Rhodes SD, Mann-Jackson L, Alonzo J, Garcia M, Tanner AE, Smart BD, Horridge DN, Dam CNV, Wilkin AM.

Driving Force of Covid-19 Among People Living With HIV/AIDS in Wuhan, China

Guo W, Ming F, Dong Y, Zhang Q, Liu L, Gao M, Zhang X, Mo P, Feng Y, Tang W, Liang K.

The Psychosocial Effects of the COVID-19 Pandemic on Youth Living with HIV in Western Kenya

Dyer J, Wilson K, Badia J, Agot K, Neary J, Njuguna I, Kibugi J, Healy E, Beima-Sofie K, John-Stewart G, Kohler P.

Case Report: COVID-19 Recovery from Triple Infection with Mycobacterium tuberculosis, HIV, and SARS-CoV-2

Rivas N, Espinoza M, Loban A, Luque O, Jurado J, Henry-Hurtado N, Goodridge A.

The COVID-19 Ibuprofen controversy; a systematic review of NSAIDs in adult acute lower respiratory tract infections

Vaja R, Chan J, Ferreira P, Harky A, Rogers LJ, Gashaw HH, Kirkby NS, Mitchell JA.

The United States National Cancer Institute's Coordinated Research Effort on Tobacco Use as a Major Cause of Morbidity and Mortality among People with HIV

Ashare RL, Bernstein SL, Schnoll R, Gross R, Catz SL, Cioe P, Crothers K, Hitsman B, Marhefka SL, McClure JB, Pacek LR, Vidrine DJ, Vilardaga R, Kaufman A, Edelman EJ.

Epidemiological, virological and serological features of COVID-19 cases in people living with HIV in Wuhan City: A population-based cohort study

Huang J, Xie N, Hu X, Yan H, Ding J, Liu P, Ma H, Ruan L, Li G, He N, Wei S, Wang X.

Characteristics and outcomes of COVID-19 in patients with HIV: a multi-center research network study

Hadi YB, Naqvi SFZ, Kupec JT, Sarwari AR.

Factors associated with hospital admission for COVID-19 in HIV patients

Di Biagio A, Ricci E, Calza L, Squillace N, Menzaghi B, Rusconi S, Orofino G, Bargiacchi O, Molteni C, Valsecchi L, Cenderello G, Ferrara S, Saracino A, Maggi P, Falasca K, Taramasso L, Bonfanti P; CISAI Study group.

Pearls and Pitfalls: two contrasting HIV diagnoses in the COVID-19 era and the case for screening

Bartilotti-Matos F, Davies P.

How to stop COVID-19 fuelling a resurgence of AIDS, malaria and tuberculosis

An HIV-infected patient with coronavirus disease 2019 has a favourable prognosis: a case report

Tian C, Tang L, Wu J, Li W, Ming X, Zhou H, Wu W, Zeng X.

Author Correction: COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19

Velez JCQ, Caza T, Larsen CP.

COVID-19 and AIDS: outcomes from the co-existence of two global pandemics and the importance of chronic antiretroviral therapy

Patel RH, Acharya A, Mohan M, Byrareddy SN.

COVID-19 related anxiety in people living with HIV: An online cross-sectional study

Kuman TunÇel Ö, PullukÇu H, Erdem HA, Kurtaran B, TaŞbakan SE, TaŞbakan M.

Editor's comment

Saag M.

HIV infection and COVID-19: risk factors for severe disease

Etienne N, Karmochkine M, Slama L, Pavie J, Batisse D, Usubillaga R, Letembet VA, Brazille P, Canouï E, Slama D, Joumaa H, Canoui-Poitrine F, Segaux L, Weiss L, Viard JP, Salmon D; COVID-19 ID Team.

Clinical characteristics, risk factors, and incidence of symptomatic COVID-19 in adults living with HIV: a single-center, prospective observational study

Inciarte A, Gonzalez-Cordon A, Rojas J, Torres B, de Lazzari E, de la Mora L, Martinez-Rebollar M, Laguno M, Callau P, Gonzalez-Navarro A, Leal L, Garcia F, Mallolas J, Mosquera M, Marcos MA, Ambrosioni J, Miro JM, Martinez E, Blanco JL; (on behalf the COVID-19 in HIV Investigators).

Antiretrovirals and risk of COVID-19 diagnosis and hospitalization in HIV-positive persons

Del Amo J, Polo R, Moreno S, Díaz A, Martínez E, Arribas JR, Jarrín I, Hernán MA; Spanish HIV/COVID-19 Collaboration.

Modelling the impact of COVID-19 on HIV

Lesosky M, Myer L.

Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models

Jewell BL, Mudimu E, Stover J, Ten Brink D, Phillips AN, Smith JA, Martin-Hughes R, Teng Y, Glaubius R, Mahiane SG, Bansi-Matharu L, Taramusi I, Chagoma N, Morrison M, Doherty M, Marsh K, Bershteyn A, Hallett TB, Kelly SL; HIV Modelling Consortium.

PEPFAR's response to the convergence of the HIV and COVID-19 pandemics in Sub-Saharan Africa

Golin R, Godfrey C, Firth J, Lee L, Minior T, Phelps BR, Raizes EG, Ake JA, Siberry GK.

Control of epidemics by jails: lessons for COVID-19 from HIV

Ohuabunwa T, Spaulding AC.

PrEP retention and prescriptions for pregnant women during COVID-19 lockdown in South Africa

Davey DLJ, Bekker LG, Mashele N, Gorbach P, Coates TJ, Myer L.

How COVID-19 could benefit tuberculosis and HIV services in South Africa

Keene C, Mohr-Holland E, Cassidy T, Scott V, Nelson A, Furin J, Triviño-Duran L.

COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19

Velez JCQ, Caza T, Larsen CP.

COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy

Calza L, Bon I, Tadolini M, Borderi M, Colangeli V, Badia L, Verucchi G, Rossini G, Vocale C, Gaibani P, Viale P, Attard L.

Achieving HIV targets by 2030: the possibility of using debt relief funds for sustainable HIV treatment in sub-Saharan Africa

Abah RC.

COVID-19 Vulnerability of Transgender Women With and Without HIV Infection in the Eastern and Southern U.S

Poteat TC, Reisner SL, Miller M, Wirtz AL.

Physical distancing due to COVID-19 disrupts sexual behaviours among gay and bisexual men in Australia: Implications for trends in HIV and other sexually transmissible infections

Hammoud MA, Maher L, Holt M, Degenhardt L, Jin J, Murphy D, Bavinton B, Grulich A, Lea T, Haire B, Bourne A, Saxton P, Vaccher S, Ellard J, Mackie B, Batrouney C, Bath N, Prestage G.

Six Lessons for COVID-19 Rehabilitation From HIV Rehabilitation

Brown DA, O'Brien KK, Josh J, Nixon SA, Hanass-Hancock J, Galantino M, Myezwa H, Fillipas S, Bergin C, Baxter L, Binette M, Chetty V, Cobbing S, Corbett C, Ibanez-Carrasco F, Kietrys D, Roos R, Solomon P, Harding R.

Impact of COVID-19 Pandemic on Sexual Minority Populations in Brazil: An Analysis of Social/Racial Disparities in Maintaining Social Distancing and a Description of Sexual Behavior

Torres TS, Hoagland B, Bezerra DRB, Garner A, Jalil EM, Coelho LE, Benedetti M, Pimenta C, Grinsztejn B, Veloso VG.

In the shadow of COVID-19: HIV-infected individuals need more attention

Zhao T, Xuan K, Uy JP, Sun C.

COVID-19 Among People Living with HIV: A Systematic Review

Mirzaei H, McFarland W, Karamouzian M, Sharifi H.

Comorbidity Indices in People with HIV and Considerations for COVID-19 Outcomes

Winston A, De Francesco D, Post F, Boffito M, Vera J, Williams I, Anderson J, Mallon PWG, Sabin CA; POPPY Study Group.

COVID-19: Understanding the science of antibody testing and lessons from the HIV epidemic

Weiss SH, Wormser GP.

The Impact of COVID-19 on Older Adults Living with HIV: HIV Care and Psychosocial Effects

Brown MJ, Weissman SB.

Variation in mortality of HIV/SARS-CoV-2 co-infected patients in the Bronx, New York City

Suwanwongse K, Shabarek N.

Association between NSAIDs use and adverse clinical outcomes among adults hospitalized with COVID-19 in South Korea: A nationwide study

Jeong HE, Lee H, Shin HJ, Choe YJ, Filion KB, Shin JY.

Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: a potential mechanism leading to poor birth outcomes in HIV-positive pregnancies

Kala S, Dunk C, Acosta S, Serghides L.

Mistakes from the HIV pandemic should inform the COVID-19 response for maternal and newborn care

Gribble K, Mathisen R, Ververs MT, Coutsoudis A.

Co-infection of other respiratory pathogens and HIV in COVID-19 patients: is there a pattern?

Barrera-López P, Pérez-Riveros ED, Moreno-Montoya J, Ballesteros SM, Valencia SA, De la Hoz-Valle JA.

SARS-CoV-2 infection in persons living with HIV: a single center prospective cohort

Maggiolo F, Zoboli F, Arosio M, Valenti D, Guarneri D, Sangiorgio L, Ripamonti D, Callegaro A.

Potential Influences of the COVID-19 Pandemic on Drug Use and HIV Care Among People Living with HIV and Substance Use Disorders: Experience from a Pilot mHealth Intervention

Hochstatter KR, Akhtar WZ, Dietz S, Pe-Romashko K, Gustafson DH, Shah DV, Krechel S, Liebert C, Miller R, El-Bassel N, Westergaard RP.

Changing the Use of HIV Pre-exposure Prophylaxis Among Men Who Have Sex With Men During the COVID-19 Pandemic in Melbourne, Australia

Chow EPF, Hocking JS, Ong JJ, Schmidt T, Buchanan A, Rodriguez E, Maddaford K, Patel P, Fairley CK.

COVID-19 affects HIV and tuberculosis care

Abdool Karim Q, Abdool Karim SS.

Case report: one case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a normal CD4(+) T cell count

Menghua W, Xin Z, Jianwei L, Yu Z, Qinwei Y.

Preserving two decades of healthcare gains for africa in the Covid-19 era

Pastakia SD, Braitstein P, Gal√°rraga O, Genberg B, Said J, Vedanthan R, Wachira J, Hogan JW.

Patterns of HIV and SARS-CoV-2 co-infection in Wuhan, China

Guo W, Ming F, Feng Y, Zhang Q, Mo P, Liu L, Gao M, Tang W, Liang K.

HIV and SARS-CoV-2: Intersecting Epidemics with Many Unknowns

Lesko CR, Bengtson AM.

COVID-19 attack rate in HIV-infected patients and in PrEP users

Charre C, Icard V, Pradat P, Brochier C, Lina B, Chidiac C, Cotte L.

HIV/SARS-CoV-2 coinfection: a global perspective

Kanwugu ON, Adadi P.

What HIV in the brain can teach us about SARS-CoV-2 neurologic complications?

Al-Harthi L, Campbell EM, Schneider JA, Bennett DA.

HIV postexposure prophylaxis during the COVID-19 pandemic: experience from Madrid

Sánchez-Rubio J, Vélez-Díaz-Pallarés M, Rodríguez González C, Sanmartin Fenollera P, García Yubero C, Fernández-Pacheco García-Valdecasas M.

Descriptive Analysis of Patients Living with HIV Affected By COVID-19

Gudipati S, Brar I, Murray S, McKinnon JE, Yared N, Markowitz N.

Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, GA

Collins LF, Moran CA, Oliver NT, Moanna A, Lahiri CD, Colasanti JA, Kelley CF, Nguyen ML, Marconi VC, Armstrong WS, Ofotokun I, Sheth AN.

Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study

Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF, Watson OJ, Whittaker C, Hamlet A, Smith JA, Winskill P, Verity R, Baguelin M, Lees JA, Whittles LK, Ainslie KEC, Bhatt S, Boonyasiri A, Brazeau NF, Cattarino L, Cooper LV, Coupland H, Cuomo-Dannenburg G, Dighe A, Djaafara BA, Donnelly CA, Eaton JW, van Elsland SL, FitzJohn RG, Fu H, Gaythorpe KAM, Green W, Haw DJ, Hayes S, Hinsley W, Imai N, Laydon DJ, Mangal TD, Mellan TA, Mishra S, Nedjati-Gilani G, Parag KV, Thompson HA, Unwin HJT, Vollmer MAC,

HIV, tuberculosis, and malaria: how can the impact of COVID-19 be minimised?

Sands P.

Challenges and similarities in HIV, COVID-19 crises: a Q&A with Anthony Fauci, MD

Fauci A, Inserro A.

Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review

Cooper TJ, Woodward BL, Alom S, Harky A.

Lessons from HIV to Guide COVID-19 Responses in the Central African Republic

Somse P, Eba PM.

Clinical characteristics in patients with SARS-CoV-2/HBV co-infection

Chen L, Huang S, Yang J, Cheng X, Shang Z, Lu H, Cheng J.

Social Support is Key to Retention in Care during Covid-19 Pandemic among Older People with HIV and Substance Use Disorders in Ukraine

Rozanova J, Shenoi S, Zaviryukha I, Zeziulin O, Kiriazova T, Rich K, Mamedova E, Yariy V.

Conducting rapid qualitative research to support sex workers' health and social needs in the face of COVID-19: capitalising on stakeholder networks from the HIV response in Singapore to drive policymaking

Tan RKJ, Lim JM, Lo JJ, Teo AKJ, O'Hara CA, Ching AH, Ho V, Wong ML.

SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States

Byrd KM, Beckwith CG, Garland JM, Johnson JE, Aung S, Cu-Uvin S, Farmakiotis D, Flanigan T, Gillani FS, Macias-Gil R, Mileno M, Ramratnam B, Rybak NR, Sanchez M, Tashima K, Mylonakis E, Kantor R.

Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic

Ferreira LMR, Mostajo-Radji MA.

[Research progress of the impact of COVID-19 outbreak on people living with HIV]

Chen FF, Tang HL, Lyu P.

Economic, Mental Health, HIV Prevention and HIV Treatment Impacts of COVID-19 and the COVID-19 Response on a Global Sample of Cisgender Gay Men and Other Men Who Have Sex with Men

Santos GM, Ackerman B, Rao A, Wallach S, Ayala G, Lamontage E, Garner A, Holloway IW, Arreola S, Silenzio V, Strömdahl S, Yu L, Strong C, Adamson T, Yakusik A, Doan TT, Huang P, Cerasuolo D, Bishop A, Noori T, Pharris A, Aung M, Dara M, Chung SY, Hanley M, Baral S, Beyrer C, Howell S.

Prevalence of COVID-19-like symptoms among people living with HIV, and using antiretroviral therapy for prevention and treatment

SeyedAlinaghi S, Ghadimi M, Hajiabdolbaghi M, Rasoolinejad M, Abbasian L, Nezhad MH, Manshadi SD, Ghadimi F, Ahmadinejad Z.

HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South Africa

Davies MA.

NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection

Cumhur Cure M, Kucuk A, Cure E.

COVID-19 and HIV co-infection an emerging consensus

Masukume G, Mapanga W, Grinberg S, van Zyl DS.

HIV and SARS CoV-2 co-infection: A retrospective, record based, case series from South India

Marimuthu J, Kumar BS, Aravind Gandhi P.

Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine; from HIV-1 infection to COVID-19

Naghipour S, Ghodousi M, Rahsepar S, Elyasi S.

Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study

Ancy I, Sivanandam M, Kumaradhas P.

When COVID-19 Crosses Paths with AIDS in the Homeless

Przydzial P, Tchomobe G, Amin K, Christian E, Okoh AK.

Learning from People with HIV: Their Insights are Critical to Our Response to the Intersecting COVID-19 and HIV Pandemics in Africa

Aristide C, Okello S, Bwana M, Siedner MJ, Peck RN.

Disproportionate burden of COVID-19 among racial minorities and those in congregate settings among a large cohort of people with HIV

Meyerowitz EA, Kim AY, Ard KL, Basgoz N, Chu JT, Hurtado RM, Lee CK, He W, Minukas T, Nelson S, Ojikutu BO, Robbins G, Sanchez S, Triant VA, Zachary K, Gandhi RT.

Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study

Del Amo J, Polo R, Moreno S, Díaz A, Martínez E, Arribas JR, Jarrín I, Hernán MA.

SARS-CoV-2 and HIV protease inhibitors: why lopinavir/ritonavir will not work for COVID-19 infection

Smolders EJ, Te Brake LH, Burger DM.

Applying the Popular Opinion Leader Intervention for HIV to COVID-19

Quinn KG.

Attendance to HIV Antiretroviral Collection Clinic Appointments During COVID-19 Lockdown. A Single Center Study in Kigali, Rwanda

Pierre G, Uwineza A, Dzinamarira T.

Clinical features and outcomes of four HIV patients with COVID-19 in Wuhan, China

Ruan L, Zhang Y, Luo Y, Yu X, Zeng Y, Peng H, Han L, Chen L, Roy S, Cheng Q, Li H, Guo X, Xiong D, Gan H, Liu M.

„Wir vermuten einen Schutzfaktor!“ : COVID-19 trifft HIV-Patienten meist nur leicht

Springer Medizin.

HIV and SARS-Coronavirus-2 Epidemics: Possible Interactions and Need for Studies, Especially in Africa

Cainelli F, Dzudzor B, Lanzafame M, Goushchi A, Chhem S, Vento S.

Coinfection with HIV and SARS-CoV-2 in Wuhan, China: A 12-person case series

Hu Y, Ma J, Huang H, Vermund SH.

Outcomes among HIV-positive patients hospitalized with COVID-19

Karmen-Tuohy S, Carlucci PM, Zervou FN, Zacharioudakis IM, Rebick G, Klein E, Reich J, Jones S, Rahimian J.

NO SIGNIFICANT EFFECT OF COVID-19 ON IMMUNOLOGICAL AND VIROLOGICAL PARAMETERS IN PATIENTS WITH HIV-1 INFECTION

Calza L, Bon I, Borderi M, Colangeli V, Viale P.

Alarm at the Gate-Health and Social Inequalities are Comorbid Conditions of HIV and COVID-19

Harris OO, Leblanc N, McGee K, Randolph S, Wharton MJ, Relf M.

Antiretroviral HIV drugs in COVID-19 research: promises and risks. An opinion piece

Waters L, Rockstroh JK.

COVID-19 in 3 people living with HIV in the United Kingdom

Toombs JM, Van den Abbeele K, Democratis J, Merricks R, Mandal AKJ, Missouris CG.

Clinical Outcomes and Prognosis of Patients with HIV and SARS-CoV-2 Co-infection

Patel RH.

Using social media and technology to communicate in pediatric HIV research: A qualitative study with young adults born with or exposed at birth to HIV

Berman CA, Kacanek D, Nichamin M, Wilson D, Davtyan M, Salomon L, Patel K, Reznick M, Tassiopoulos K, Lee S, Bauermeister J, Paul M, Aldape T, Seage Iii G.

Structural Biology Aids the Research of New Anti-COVID-19 Drugs

Lu J, Liu X.

Intersecting Pandemics: Impact of SARS-CoV-2 (COVID-19) Protective Behaviors on People Living with HIV, Atlanta, Georgia

Kalichman SC, Eaton LA, Berman M, Kalichman MO, Katner H, Sam SS, Caliendo AM.

Personal historical perspective of HIV: part 11

Welsby PD.

Addressing Health Inequities Exacerbated by COVID-19 Among Youth With HIV: Expanding Our Toolkit

Armbruster M, Fields EL, Campbell N, Griffith DC, Kouoh AM, Knott-Grasso MA, Arrington-Sanders R, Agwu AL.

Letter to the Editor: The characteristics of two patients co-infected with SARS-CoV-2 and HIV in Wuhan, China

Li W, Ma Q, Wang X, Tang M, Lin J, Xiao B.

The COVID-19 response must integrate people living with HIV needs in Sub-Saharan Africa: the case of Mali

Sagaon-Teyssier L, Yattassaye A, Bourrelly M, Dembélé Keïta B, Spire B.

Predicting the Immunogenicity of T cell epitopes: From HIV to SARS-CoV-2

Gao A, Chen Z, Segal FP, Carrington M, Streeck H, Chakraborty AK, Julg B.

All-in-One Dual CRISPR-Cas12a (AIOD-CRISPR) Assay: A Case for Rapid, Ultrasensitive and Visual Detection of Novel Coronavirus SARS-CoV-2 and HIV virus

Ding X, Yin K, Li Z, Liu C.

Telemedicine as a tool for PrEP delivery during the COVID-19 pandemic in a large HIV prevention service in Rio de Janeiro-Brazil

Hoagland B, Torres TS, Bezerra DRB, Geraldo K, Pimenta C, Veloso VG, Grinsztejn B.

Potential impact of COVID-19 in people living with HIV: experience from previous 21st century coronaviruses epidemics

Dauby N.

How to Have Sex in an Epidemic Redux: Reinforcing HIV Prevention in the COVID-19 Pandemic

Newman PA, Guta A.

NSAIDs for analgesia in the era of COVID-19

Herzberg DL, Sukumaran HP, Viscusi E.

Home Birth in the Era of COVID-19: Counseling and Preparation for Pregnant Persons Living with HIV

Premkumar A, Cassimatis I, Berhie SH, Jao J, Cohn SE, Sutton SH, Condron B, Levesque J, Garcia PM, Miller ES, Yee LM.

Living with HIV in the time of COVID-19: a glimpse of hope

Adadi P, Kanwugu ON.

Laser Safety Measures for The Treatment of Genital Warts in Hiv+ Patients During The Covid-19 Pandemic

Cameli N, Mariano M, Latini A, Morrone A, Cristaudo A.

Recovery from COVID-19 following Hepatitis C, Human Immunodeficiency Virus Infection and Liver Transplantation

Müller H, Kniepeiss D, Stauber R, Schrem H, Rauter M, Krause R, Schemmer P.

A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan

Nakamoto T, Kutsuna S, Yanagawa Y, Kanda K, Okuhama A, Akiyama Y, Miyazato Y, Ide S, Nakamura K, Yamamoto K, Ohmagari N.

Impact of the COVID-19 Pandemic on HIV Testing and Assisted Partner Notification Services, Western Kenya

Lagat H, Sharma M, Kariithi E, Otieno G, Katz D, Masyuko S, Mugambi M, Wamuti B, Weiner B, Farquhar C.

COVID-19 Lockdowns: Impact on Facility-Based HIV Testing and the Case for the Scaling Up of Home-Based Testing Services in Sub-Saharan Africa

Mhango M, Chitungo I, Dzinamarira T.

In the shadow of HIV & TB: A commentary on the COVID epidemic in South Africa

Bulled N, Singer M.

COVID-19 pneumonia in patients with HIV - A Case Series

Okoh AK, Bishburg E, Grinberg S, Nagarakanti S.

The Clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease

Dursun R, Temiz SA.

COVID-19 in people with HIV

Xu Z, Zhang C, Wang FS.

Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort

Vizcarra P, Pérez-Elías MJ, Quereda C, Moreno A, Vivancos MJ, Dronda F, Casado JL; COVID-19 ID Team.

Clinical characteristics and outcomes in people living with HIV hospitalized for COVID-19

Shalev N, Scherer M, LaSota ED, Antoniou P, Yin MT, Zucker J, Sobieszczyk ME.

A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois

Ridgway JP, Farley B, Benoit JL, Frohne C, Hazra A, Pettit N, Pho M, Pursell K, Saltzman J, Schmitt J, Uvin AZ, Pitrak D, McNulty M.

HIV postexposure prophylaxis during COVID-19

Junejo M, Girometti N, McOwan A, Whitlock G; Dean Street Collaborative Group.

Clinical features and outcome of HIV/SARS-CoV-2 co-infected patients in the Bronx, New York City

Suwanwongse K, Shabarek N.

Adapting Substance Use Treatment for HIV Affected Communities During COVID-19: Comparisons Between a Sexually Transmitted Infections (STI) Clinic and a Local Community Based Organization

Rogers BG, Arnold T, Schierberl Scherr A, Strong SH, Holcomb R, Daley Ndoye C, Pinkston M, Chan PA.

Hospitalized patients with COVID-19 and HIV: a case series

Childs K, Post FA, Norcross C, Ottaway Z, Hamlyn E, Quinn K, Juniper T, Taylor C.

The effects of COVID-19 on the health and socio-economic security of sex workers in Nairobi, Kenya: Emerging intersections with HIV

Kimani J, Adhiambo J, Kasiba R, Mwangi P, Were V, Mathenge J, Macharia P, Cholette F, Moore S, Shaw S, Becker M, Musyoki H, Bhattacharjee P, Moses S, Fowke KR, McKinnon LR, Lorway R.

Concealment of Potential Exposure to COVID-19 and Its Impact on Outbreak Control: Lessons from the HIV Response

Teo AKJ, Tan RKJ, Prem K.

COVID-19 in an HIV-positive Kidney Transplant Recipient

Kumar RN, Tanna SD, Shetty AA, Stosor V.

"Everything is a Mess": How COVID-19 is Impacting Engagement with HIV Testing Services in Rural Southwestern Uganda

Ponticiello M, Mwanga-Amumpaire J, Tushemereirwe P, Nuwagaba G, King R, Sundararajan R.

Reimagining the Future of HIV Service Implementation in the Philippines Based on Lessons from COVID-19

Quilantang MIN, Bermudez ANC, Operario D.

Covid-19 and Gender in LMICs: Potential Lessons from HIV Pandemic

Small E, Sharma BB, Nikolova SP.

COVID-19 and Hidden Housing Vulnerabilities: Implications for Health Equity, New Haven, Connecticut

Rosenberg A, Keene DE, Schlesinger P, Groves AK, Blankenship KM.

COVID-19 in a patient with HIV infection

Patel RH, Pella PM.

Adapting to the COVID-19 Pandemic: Continuing HIV Prevention Services for Adolescents Through Telemonitoring, Brazil

Dourado I, Magno L, Soares F, Massa P, Nunn A, Dalal S, Grangeiro A; Brazilian PrEP1519 Study Group.

Disinformation, Misinformation and Inequality-Driven Mistrust in the Time of COVID-19: Lessons Unlearned from AIDS Denialism

Jaiswal J, LoSchiavo C, Perlman DC.

Clinical Care, Research, and Telehealth Services in the Era of Social Distancing to Mitigate COVID-19

Young SD, Schneider J.

COVID-19, Telemedicine, and Patient Empowerment in HIV Care and Research

Mgbako O, Miller EH, Santoro AF, Remien RH, Shalev N, Olender S, Gordon P, Sobieszczyk ME.

HIV and SARS-CoV-2 co-infection: A case report from Uganda

Baluku JB, Mwebaza S, Ingabire G, Nsereko C, Muwanga M.

The impact of COVID-19 on HIV financing in Nigeria: a call for proactive measures

Oladele TT, Olakunde BO, Oladele EA, Ogbuoji O, Yamey G.

Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs Against Human Coronavirus 229E (HCoV-229E)

Parang K, El-Sayed NS, Kazeminy AJ, Tiwari RK.

Encephalopathy and seizure activity in a COVID-19 well controlled HIV patient

Haddad S, Tayyar R, Risch L, Churchill G, Fares E, Choe M, Montemuro P.

What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control?

Amimo F, Lambert B, Magit A.

COVID-19 in patients with HIV.

Jones R, Nelson M, Bracchi M, Asboe D, Boffito M.

COVID-19 in patients with HIV - Authors' reply.

Miró JM, Ambrosioni J, Blanco JL.

FAKE SCIENCE: XMRV, COVID-19 AND THE TOXIC LEGACY OF DR JUDY MIKOVITS.

Neil S, Campbell EM.

HIV care in times of the COVID-19 crisis - where are we now in Central and Eastern Europe?

COVID-19 Comes 40 Years After AIDS - Any Lesson?

Soriano V, Barreiro P, Ramos JM, Eirós JM, de Mendoza C.

Clinical features and outcomes of HIV patients with coronavirus disease 2019.

Gervasoni C, Meraviglia P, Riva A, Giacomelli A, Oreni L, Minisci D, Atzori C, Ridolfo A, Cattaneo D.

COVID-19, HIV, and Migrant Workers: The Double Burden of the Two Viruses.

Lodge W 2nd, Kuchukhidze S.

Why Aren't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)?

Laurence J.

A case of HIV and SARS-CoV-2 co-infection in Singapore.

Recovery from COVID-19 in two patients with coexisted HIV infection.

Wu Q, Chen T, Zhang H.

Confronting Another Pandemic: Lessons from HIV can Inform Our COVID-19 Response.

Edelman EJ, Aoun-Barakat L, Villanueva M, Friedland G.

COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients.

Härter G, Spinner CD, Roider J, Bickel M, Krznaric I, Grunwald S, Schabaz F, Gillor D, Postel N, Mueller MC, Müller M, Römer K, Schewe K, Hoffmann C.

Keep It Going if You Can": HIV Service Provision for Priority Populations During the COVID-19 Pandemic in Seattle, WA.

Beima-Sofie K, Ortblad KF, Swanson F, Graham SM, Stekler JD, Simoni JM.

HIV and Food Insecurity: A Syndemic Amid the COVID-19 Pandemic.

McLinden T, Stover S, Hogg RS.

Challenges to HIV Care and Psychological Health During the COVID-19 Pandemic Among People Living with HIV in China.

Sun S, Hou J, Chen Y, Lu Y, Brown L, Operario D.

HIV Care Continuum and COVID-19 Outcomes Among People Living with HIV During the COVID-19 Pandemic, Chicago, IL.

Ridgway JP, Schmitt J, Friedman E, Taylor M, Devlin S, McNulty M, Pitrak D.

The time is now: expedited HIV differentiated service delivery during the COVID-19 pandemic.

The anti-HIV Drug Nelfinavir Mesylate (Viracept) is a Potent Inhibitor of Cell Fusion Caused by the SARS-CoV-2 Spike (S) Glycoprotein Warranting further Evaluation as an Antiviral against COVID-19 infections.

Musarrat F, Chouljenko V, Dahal A, Nabi R, Chouljenko T, Jois SD, Kousoulas KG.

A personal historical perspective of HIV.

Welsby PD.

Covid-19-The real role of NSAIDs in Italy.

de Girolamo L, Peretti GM, Maffulli N, Brini AT.

Lessons learned from HIV can inform our approach to COVID-19 stigma.

Assessing HIV-Related Stigma in Healthcare Settings in the Era of the COVID-19 Pandemic, Pittsburgh, Pennsylvania.

Krier S, Bozich C, Pompa R, Friedman MR.

Routine Screening for HIV in an Urban Emergency Department During the COVID-19 Pandemic.

Stanford KA, Friedman EE, Schmitt J, Spiegel T, Ridgway JP, Moore M, Taylor M, Pitrak D, McNulty MC.

NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?

A COVID-19 conference at AIDS 2020: Virtual.

COVID-19 and Antiretroviral Therapies: South Africa's Charge Towards 90-90-90 in the Midst of a Second Pandemic.

Mendelsohn AS, Ritchwood T.

Prioritizing Community Partners and Community HIV Workers in the COVID-19 Pandemic.

Operario D, King EJ, Gamarel KE.

Considerations for STI Clinics during the COVID-19 pandemic.

Napoleon SC, Maynard MA, Almonte A, Cormier K, Bertrand T, Ard KL, Chan PA.

Characterizing the Impact of COVID-19 on Men Who Have Sex with Men Across the United States in April, 2020.

Sanchez TH, Zlotorzynska M, Rai M, Baral SD.

Development of Telemedicine Infrastructure at an LGBTQ+‚ÄâClinic to Support HIV Prevention and Care in Response to COVID-19, Providence, RI.

Rogers BG, Coats CS, Adams E, Murphy M, Stewart C, Arnold T, Chan PA, Nunn A.

HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey.

Altuntas Aydin O, Kumbasar Karaosmanoglu H, Kart Yasar K.

COVID-19: Increased Risk to the Mental Health and Safety of Women Living with HIV in South Africa.

Joska JA, Andersen L, Rabie S, Marais A, Ndwandwa ES, Wilson P, King A, Sikkema KJ.

Rapid Implementation of Service Delivery Changes to Mitigate COVID-19 and Maintain Access to Methadone Among Persons with and at High-Risk for HIV in an Opioid Treatment Program.

Peavy KM, Darnton J, Grekin P, Russo M, Green CJB, Merrill JO, Fotinos C, Woolworth S, Soth S, Tsui JI.

COVID-19 Pandemic Disrupts HIV Continuum of Care and Prevention: Implications for Research and Practice Concerning Community-Based Organizations and Frontline Providers.

Pinto RM, Park S.

The Virus that Changed Spain: Impact of COVID-19 on People with HIV.

Ballester-Arnal R, Gil-Llario MD.

Contact tracing for COVID-19: An opportunity to reduce health disparities and End the HIV/AIDS Epidemic in the US.

Nosyk B, Armstrong WS, Del Rio C.

COVID-19 Policies can Perpetuate Violence Against Transgender Communities: Insights from Peru.

Perez-Brumer A, Silva-Santisteban A.

Case Report: One Case of Coronavirus Desease 2019(COVID-19) in Patient Co-nfected by HIV With a Low CD4+ T Cell Count.

Wang M, Luo L, Bu H, Xia H.

The Impact of COVID-19 on Syringe Services Programs in the United States.

Glick SN, Prohaska SM, LaKosky PA, Juarez AM, Corcorran MA, Des Jarlais DC.

From HIV to Coronavirus: AIDS Service Organizations Adaptative Responses to COVID-19, Birmingham, Alabama.

Kay ES, Musgrove K.

COVID-19-Compliant Strategies for Supporting Treatment Adherence Among People Living with HIV in Sub-Saharan Africa.

Nyoni T, Okumu M.

Social and behavioral health responses to COVID-19: lessons learned from four decades of an HIV pandemic.

Eaton LA, Kalichman SC.

Physical Distancing in COVID-19 May Exacerbate Experiences of Social Isolation among People Living with HIV.

Marziali ME, Card KG, McLinden T, Wang L, Trigg J, Hogg RS.

Darunavir does not prevent SARS-CoV-2 infection in HIV patients.

Riva A, Conti F, Bernacchia D, Pezzati L, Sollima S, Merli S, Siano M, Lupo A, Rusconi S, Cattaneo D, Gervasoni C.

Raids on Immigrant Communities During the Pandemic Threaten the Country's Public Health.

Lopez MM, Holmes SM.

SARS-CoV-2 pandemic expanding in sub-Saharan Africa: Considerations for COVID-19 in people living with HIV.

Drain PK, Garrett N.

Infection of severe acute respiratory syndrome coronavirus 2 in a patient with acquired immunodeficiency syndrome.

Su J, Shen X, Ni Q, Zhao H, Cai J, Zhu B, Wu W, Lang G, Xu K, Sheng J.

Maximizing Digital Interventions for Youth in the Midst of Covid-19: Lessons from the Adolescent Trials Network for HIV Interventions.

Hightow-Weidman L, Muessig K, Claude K, Roberts J, Zlotorzynska M, Sanchez T.

Unlikely SARS-CoV-2 vertical transmission from mother to child: A case report.

Peng Z, Wang J, Mo Y, Duan W, Xiang G, Yi M, Bao L, Shi Y.

COVID-19 in patients with HIV: clinical case series.

Blanco JL, Ambrosioni J, Garcia F, Martínez E, Soriano A, Mallolas J, Miro JM; COVID-19 in HIV Investigators..

The Burden of COVID-19 in People Living with HIV: A Syndemic Perspective.

Shiau S, Krause KD, Valera P, Swaminathan S, Halkitis PN.

Research in the Time of Coronavirus: Continuing Ongoing Studies in the Midst of the COVID-19 Pandemic.

Saberi P.

Symptoms, Stress, and HIV-Related Care Among Older People Living with HIV During the COVID-19 Pandemic, Miami, Florida.

Algarin AB, Varas-Rodríguez E, Valdivia C, Fennie KP, Larkey L, Hu N, Ibañez GE.

Collective Call to Action for HIV/AIDS Community-Based Collaborative Science in the Era of COVID-19.

Shoptaw S, Goodman-Meza D, Landovitz RJ.

Understanding the Impact of COVID-19 on Latino Sexual Minority Men in a US HIV Hot Spot.

Harkness A, Behar-Zusman V, Safren SA.

Demographic science aids in understanding the spread and fatality rates of COVID-19.

Dowd JB, Andriano L, Brazel DM, Rotondi V, Block P, Ding X, Liu Y, Mills MC.

Three lessons for the COVID-19 response from pandemic HIV.

Hargreaves J, Davey C; Group for lessons from pandemic HIV prevention for the COVID-19 response..

Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better.

Mascolo S, Romanelli A, Carleo MA, Esposito V.

Computed Tomography Imaging of an HIV-infected Patient with Coronavirus Disease 2019 (COVID-19).

Chen J, Cheng X, Wang R, Zeng X.

Contracting HIV or Contracting SAR-CoV-2 (COVID- 19) in Pregnancy? Balancing the Risks and Benefits.

Joseph Davey D, Bekker LG, Coates TJ, Myer L.

What's Old is New! Similarities Between SARS-CoV-2 and HIV.

Relf MV.

Tuberculosis and HIV responses threatened by COVID-19.

Adepoju P.

Tested by HIV and TB, South Africa confronts new pandemic.

Maintaining HIV care during the COVID-19 pandemic.

Jiang H, Zhou Y, Tang W.

Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV.

Zhao J, Liao X, Wang H, Wei L, Xing M, Liu L, Zhang Z.

Reply to Comments on 'Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China'.

Zhu F, Cao Y, Xu S, Zhou M.

How Do We Balance Tensions Between COVID-19 Public Health Responses and Stigma Mitigation? Learning from HIV Research.

Logie CH, Turan JM.

Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19.

Carrico AW, Horvath KJ, Grov C, Moskowitz JT, Pahwa S, Pallikkuth S, Hirshfield S.

COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?

Russell B, Moss C, Rigg A, Van Hemelrijck M.

Covid-19: NICE advises against using NSAIDs for fever in patients with suspected cases.

Torjesen I.

The Impacts of Isolation Measures Against SARS-CoV-2 Infection on Sexual Health.

Alpalh√£o M, Filipe P.

EMA advice on the use of NSAIDs for Covid-19.

[No authors listed]

Editorial: Managing the march of COVID-19: lessons from the HIV and AIDS epidemic.

Whiteside A, Parker W, Schramm M.

[Quick community survey on the impact of COVID-19 outbreak for the healthcare of people living with HIV].

Guo W, Weng HL, Bai H, Liu J, Wei XN, Zhou K, Sande A.

SARS-CoV-2 and HIV.

Joob B, Wiwanitkit V.

Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1.

Zhang C, Zheng W, Huang X, Bell EW, Zhou X, Zhang Y.

Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China.

Zhu F, Cao Y, Xu S, Zhou M.

HIV-1 did not contribute to the 2019-nCoV genome.

Xiao C, Li X, Liu S, Sang Y, Gao SJ, Gao F.